Fentanyl test strips should be legal in Pennsylvania, auditor general says | TribLIVE.com
Pennsylvania

Fentanyl test strips should be legal in Pennsylvania, auditor general says

Deb Erdley
1815599_web1_Fentanyl
State police in Greensburg seized three pounds six ounces of straight fentanyl Monday from two New York men during traffic stop along turnpike in Mt. Pleasant Twp. Monday. July 8, 2019.

Citing the growing role of fentanyl in drug overdoses, Pennsylvania Auditor General Eugene DePasquale on Wednesday called on state lawmakers to legalize fentanyl test strips.

The call was among the top recommendations DePasquale released in a new report, “A Deadly Dose: Fentanyl’s Impact on Pennsylvania.”

The two-term auditor general, who is mounting a Democratic primary campaign in Pennsylvania’s 10th Congressional District in eastern Pennsylvania, said the state and federal governments must do more to combat the scourge of fentanyl.

DePasquale said reports showed the synthetic opioid was among the three deadliest drugs in every Pennsylvania county that tracked data in 2017 and contributed to a 65% increase in overdose deaths between 2015 and 2017.

“Fentanyl, which can be 50 times more powerful than heroin, is often present in street drugs such as heroin and cocaine, but users don’t realize it,” DePasquale said. “Beyond the tragic cost in lives lost to overdoses, the fentanyl epidemic is driving billions of dollars in costs to Pennsylvania taxpayers and our economy.”

Authorities said the widespread introduction of fentanyl into street drugs was a factor in the dramatic spike in overdose deaths across the region in 2016 and 2017.

Although overdose deaths declined in 2018, fentanyl was a factor in 88 of 120 overdose deaths in Westmoreland County alone, records show.

Fentanyl strips, which are classified as drug paraphernalia and illegal in Pennsylvania, can show whether a drug contains the potent opioid and alert drug users to danger, DePasquale said.

“The General Assembly should act to make test strips legal and widely available because they can help to save lives,” DePasquale said.

He said there are already at least two bills pending in the Legislature that would do that and called on lawmakers to pass them and “get them to the governor’s desk.”

Now that fentanyl has become a major contributor to the opioid epidemic, the costs alone should move lawmakers to act, DePasquale said.

He quoted the White House Council of Economic Advisors report that estimated that the opioid epidemic cost the U.S. approximately $500 billion per year in health care and treatment costs, criminal justice costs, lost productivity and mortality costs.

“Pennsylvania’s share of that cost is roughly $25 billion per year – or nearly $2,000 per person,” DePasquale said.

Although it’s difficult to parse out the total cost to Pennsylvania taxpayers and insurers, DePasquale said the cost of opioid treatment billed to Medicaid alone cost $178 million last year.

Deb Erdley is a Tribune-Review staff writer. You can contact Deb at 724-850-1209, [email protected] or via Twitter .

Categories: News | Pennsylvania | Top Stories
TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.